Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaGreen is a Canadian biotechnology company specializing in the sustainable extraction of high-value bioactive compounds from agricultural biomass. Utilizing proprietary green fractionation technology, the company produces premium ingredients such as inulin, xylitol, and cellulose from crops like Jerusalem artichoke. These products serve as critical components in the pharmaceutical, nutraceutical, and functional food industries, targeting health areas such as glycemic control and digestive wellness. NovaGreen's business model focuses on a zero-waste approach, converting agricultural residues into valuable health-promoting substances and industrial materials. The company is positioned as a key supplier of plant-derived, sustainable alternatives to synthetic ingredients in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova Green.